SCHEMBL23309498

SCHEMBL23309498

N#Cc1ccsc1NC(=O)c1cc(F)nc(F)c1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.55
▸ KMT2A Q03164 9/20 0.55
▸ KDM4E B2RXH2 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ ALOX15 P16050 1/20 0.50
▸ SMN1; SMN2 Q16637 6/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ RAB9A P51151 5/20 0.43
▸ POLB P06746 4/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ LMNA P02545 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309709 0.79 EPHB3 (0.50) MEN1KMT2AKDM4EALDH1A1ALOX15
SCHEMBL23309473 0.78 KMT2A (0.61) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL23309625 0.76 HSD17B10 (0.37) MEN1KMT2AKDM4EALDH1A1ALOX15
SCHEMBL23309521 0.75 GRM5 (0.51) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL23309730 0.73 KMT2A (0.47) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL23309512 0.72 HTT (0.57) MEN1KMT2AALDH1A1ALOX15SMN1; SMN2
SCHEMBL23309488 0.72 CYP1A2 (0.52) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL23200351 0.71 ALDH1A1 (0.60) MEN1KMT2AKDM4EALDH1A1ALOX15
SCHEMBL3510937 0.70 SMN1; SMN2 (0.61) MEN1KMT2AKDM4EALDH1A1ALOX15
SCHEMBL23309490 0.70 GAA (0.51) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MEN1 1633/4885KMT2A 2360/4885KDM4E 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback